Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

• Status: Completed
• Trial end date: 2004-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UCB Pharma
• Treatments: Cetirizine; Levocetirizine

Criteria

Inclusion Criteria:

• male or female subjects ≥ 12 years

• 2 year history of seasonal allergic rhinitis

• documented hypersensitivity to local seasonal allergens (grass pollen)

• documented pollen-induced asthma

• without acute ongoing exacerbation of asthma or allergic rhinitis

• no continuous ongoing treatment for rhinitis or asthma

Exclusion Criteria:

• non-allergic rhinitis and anatomic abnormalities disturbing the analysis of nasal capacity

• symptomatic rhinitis or asthma due to tree pollens

• currently treated by specific grass pollen immunotherapy

• suffering from non-allergic asthma

• chronic use of inhaled steroids and/or long acting β2 agonists; and/or corticosteroid dependent asthma

• atopic dermatitis or urticaria requiring an antihistamine treatment or the administration of oral or topical corticosteroids

• contraindication for salbutamol use